Literature DB >> 26349593

The long-term impact of various techniques for tricuspid repair in Ebstein's anomaly.

Roland Hetzer1, Paul Hacke2, Mariano Javier1, Oliver Miera2, Katharina Schmitt2, Yuguo Weng1, Eva Maria Delmo Walter3.   

Abstract

OBJECTIVE: We describe a repertoire of repair techniques according to type of Ebstein's anomaly to correct tricuspid valve (TV) incompetence, and report long-term ventricular function and functional outcomes.
METHODS: Sixty-eight patients (mean age, 26.9 ± 7.3 years) with Ebstein's anomaly (type A, n = 21; type B, n = 23; type C, n = 15; type D, n = 9) underwent correction of TV incompetence under normothermic cardiopulmonary bypass. The atrialized ventricle, TV, and subvalvar apparatus were inspected to analyze the precise morphology and determine which leaflet was the most mobile. Various repair strategies (anterior and/or posterior annulorrhapy, Sebening stitich, double-orifice valve technique, with bidirectional Glenn anastomosis if necessary) were used according to the presenting morphology and applied according to the type of Ebstein's anomaly. In all, the atrialized right ventricle (RV) was incorporated into the contractile RV by partial closure of the natural annulus using the most mobile leaflet for valve competence.
RESULTS: The mean duration of follow-up was 13.25 ± 1.3 years (median, 9.34 years; range, 1-24 years). The mean New York Heart Association class improved from 3.4 to 1.3 (P < .001). The mean severity of TV incompetence was reduced from 3.2 to 1.3 (P < .001). Exercise tolerance tests demonstrated improved maximal oxygen uptake from a mean of 15 ± 7.8 ng/kg/min preoperatively to a mean of 24.9 ± 2.0 ng/kg/min postoperatively (P < .02). Displacement tissue Doppler imaging was used to evaluate overall cardiac performance of the RV and left ventricle and interventricular septum. The mean basal, middle, and apical ventricular strain improved significantly from preoperative values of 18.08%, 15.6%, and 13.9%, respectively to postoperative values of 25.7% (P < .011), 23.7% (P < .001), and 19.36% (P < .05), respectively. Freedom from reoperation was 100% at 1 year, 98.3% at 5 years, and 92.9% at 20 years. Early mortality was 2.9%, and late mortality was 5.8%. The overall survival rate was 97.6% at 30 days, 92.7% at 5 years, and 91.26% at 20 years.
CONCLUSIONS: The various repair techniques, all of which preserve the atrialized chamber and are used individually according to morphology, provide satisfactory long-term ventricular function and functional outcome even in severe types of Ebstein's anomaly.
Copyright © 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ebstein's anomaly; atrialized chamber; tricuspid valve; ventricular function

Mesh:

Year:  2015        PMID: 26349593     DOI: 10.1016/j.jtcvs.2015.08.036

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Ventricular arrhythmias and sudden death in patients with Ebstein anomaly: insights from a retrospective cohort study.

Authors:  Victor Waldmann; Paul Khairy
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Mid-term outcomes of individualized surgeries in patients with Ebstein's anomaly.

Authors:  Jiaquan Zhu; Li Zhang; Chunrong Bao; Fangjie Xu; Fangbao Ding; Ju Mei
Journal:  Heart Vessels       Date:  2019-03-08       Impact factor: 2.037

Review 3.  Narrative review of Ebstein's anomaly beyond childhood: Imaging, surgery, and future perspectives.

Authors:  Stephan Neumann; André Rüffer; Jörg Sachweh; Daniel Biermann; Jochen Herrmann; Michael Jerosch-Herold; Mark Hazekamp; Christoph Sinning; Elvin Zengin; Stefan Blankenberg; Evaldas Girdauskas; Hermann Reichenspurner; Torben Kehl; Götz Müller; Rainer Kozlik-Feldmann; Carsten Rickers
Journal:  Cardiovasc Diagn Ther       Date:  2021-12

4.  Early and Long-Term Outcomes of Surgical Treatment of Ebstein's Anomaly.

Authors:  Guilherme Viotto Rodrigues da Silva; Leonardo Augusto Miana; Luiz Fernando Caneo; Aída Luiza Ribeiro Turquetto; Carla Tanamati; Juliano G Penha; Fabio B Jatene; Marcelo B Jatene
Journal:  Braz J Cardiovasc Surg       Date:  2019-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.